Medical University of Lodz
Welcome,         Profile    Billing    Logout  
 8 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kuna, Piotr
ANCHOR-2, NCT05281523 / 2021-005055-36: Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Active, not recruiting
3
264
Europe, Japan, US, RoW
Depemokimab (GSK3511294), Placebo
GlaxoSmithKline
Nasal Polyps
07/24
08/24
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Recruiting
2
464
Europe, RoW
Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo
Chiesi Farmaceutici S.p.A.
Uncontrolled Asthma
12/25
12/25
KOSTKA, TOMASZ
POSITIVE, NCT04592146: Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs

Recruiting
N/A
150
Europe
Frailty multicomponent intervention supported by POSITIVE, Frailty multicomponent intervention
Hospital Universitario Getafe, Karolinska Institutet, Medical Universtity of Lodz, Universidad Politecnica de Madrid, KTH Royal Institute of Technology, Fundación para la Investigación Biomédica - Hospital Universitario de Getafe
Frailty, Frailty Syndrome, Frail Elderly Syndrome
06/21
06/21
Pigłowska, Małgorzata
POSITIVE, NCT04592146: Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs

Recruiting
N/A
150
Europe
Frailty multicomponent intervention supported by POSITIVE, Frailty multicomponent intervention
Hospital Universitario Getafe, Karolinska Institutet, Medical Universtity of Lodz, Universidad Politecnica de Madrid, KTH Royal Institute of Technology, Fundación para la Investigación Biomédica - Hospital Universitario de Getafe
Frailty, Frailty Syndrome, Frail Elderly Syndrome
06/21
06/21
Mlynarski, Wojciech
RaRE-TS, NCT05534672: Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Recruiting
3
200
Europe
Rapamycin, Placebo
Katarzyna Kotulska
Tuberous Sclerosis Complex
06/27
06/27
NCT04501614 / 2019-002549-39: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Active, not recruiting
1/2
68
Europe, US, RoW
Ponatinib, Ponatinib AAF, Chemotherapy Agents
Takeda, Takeda Development Center Americas, Inc.
Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL)
12/24
01/27
Miller, Elzbieta
NCT05750303: Potential Prognostic Markers of Recovery in Post-stroke Rehabilitation

Completed
N/A
32
Europe
Medical University of Lodz, University of Lodz
Ischemic Stroke
01/23
01/23

Download Options